Prostate carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4388
|
1168
|
0.010 |
None |
< 0.001 |
1 |
|
2017 |
2017 |
Hemoglobin measurement
|
phenotype |
|
Laboratory Procedure
|
131
|
224
|
0.100 |
None |
1.000 |
1 |
2
|
2016 |
2016 |
Malignant neoplasm of kidney
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
664
|
22
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Stomach Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
3720
|
652
|
0.010 |
None |
1.000 |
1 |
1
|
2014 |
2014 |
Invasive Ductal Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
414
|
16
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Malignant neoplasm of colon and/or rectum
|
disease |
|
Neoplastic Process
|
3669
|
502
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Mantle cell lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
466
|
19
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
MIXED LINEAGE LEUKEMIA
|
disease |
|
Neoplastic Process
|
240
|
2
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Refractory Cytopenia of Childhood
|
disease |
|
Neoplastic Process
|
264
|
3
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding)
|
phenotype |
|
Finding
|
12
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
DOSAGE-SENSITIVE SEX REVERSAL
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
159
|
12
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Oxyphilic Adenoma
|
disease |
Neoplasms
|
Neoplastic Process
|
114
|
3
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Renal carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
665
|
21
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Atrophic iris
|
disease |
Eye Diseases
|
Disease or Syndrome
|
9
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Pouchitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
38
|
10
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Hematopoietic Neoplasms
|
group |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
322
|
2
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Paraganglioma
|
disease |
Neoplasms
|
Neoplastic Process
|
165
|
36
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Nicotine Dependence
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
170
|
178
|
0.010 |
None |
1.000 |
1 |
1
|
2014 |
2014 |
melanoma
|
disease |
Neoplasms
|
Neoplastic Process
|
3087
|
515
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Malignant neoplasm of stomach
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
3806
|
615
|
0.010 |
None |
1.000 |
1 |
1
|
2014 |
2014 |
Leukemia, T-Cell
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
457
|
10
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Hematocrit procedure
|
phenotype |
|
Laboratory Procedure
|
138
|
216
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Glioma
|
disease |
Neoplasms
|
Neoplastic Process
|
3097
|
353
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Red Blood Cell Count measurement
|
phenotype |
|
Laboratory Procedure
|
717
|
1599
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |